The socio-economic impact of a breakthrough in the particle accelerators' technology: a research agenda
Massimo Florio, Andrea Bastianin, Paolo Castelnovo

TL;DR
This paper explores how to evaluate the socio-economic benefits of breakthroughs in accelerator technology, proposing a model for social cost-benefit analysis and outlining a research agenda for assessing industry impacts.
Contribution
It introduces a novel social cost-benefit analysis model for research infrastructures and presents a research agenda for understanding the impacts of technological breakthroughs in accelerators.
Findings
Model applied to assess benefits in basic science and hadrontherapy
Identifies key stakeholders interested in accelerator breakthroughs
Proposes a framework for evaluating industry-wide impacts
Abstract
Preliminary evidence on the long--run trajectory of the accelerator industry suggests that it may be close to the maturity phase of its cycle. If this is the case, how can we measure the benefits of an uncertain breakthrough in acceleration technology? Who are the main stakeholders interested by such a breakthrough? We identify these subjects and sketch some avenues for answering these questions. We thus present a model for the social Cost-Benefit Analysis (CBA) of research infrastructures and illustrate the results of its implementation for assessing the benefits of accelerators in basic science and hadrontherapy. Lastly, we move from the social CBA of single research infrastructures to modeling a major change in the accelerator technology and hence in the industry. A research agenda on the potential impacts of a technological breakthrough is presented.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInternational Science and Diplomacy · Health and Medical Research Impacts · Innovation Policy and R&D
